Drug Shortage Report for CISATRACURIUM OMEGA MULTIDOSE
| Report ID | 109806 |
| Drug Identification Number | 02408813 |
| Brand name | CISATRACURIUM OMEGA MULTIDOSE |
| Common or Proper name | Cisatracurium Besylate Injection |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CISATRACURIUM |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10 x 10mL vial / fiole |
| ATC code | M03AC |
| ATC description | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2020-03-17 |
| Estimated end date | Unknown |
| Actual end date | 2020-06-01 |
| Shortage status | Resolved |
| Updated date | 2020-06-09 |
| Company comments | Preventive Allocation (COVID-19) |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-06-09 | French | Compare |
| v3 | 2020-06-09 | English | Compare |
| v2 | 2020-03-30 | French | Compare |
| v1 | 2020-03-30 | English | Compare |
Showing 1 to 4 of 4